Citations

Clear

3030 citation(s) found for "Susan, M".

Eleven-Year Experience with Selective Adrenal Vein Sampling in Management of Primary Adrenal Hormonal Hypersecretion
Asbun, Domenech , Cheng, Yilon Lima , Bush, Weston, Samson, Susan L. , Meek, Shon , Paz‐Fumagalli, Ricardo , Lewis, Andrew R. , Gabriel, Emmanuel , Asbun, Horacio J. , Elli, Enrique F. , Lewis, Andrew , Asbun, Horacio, Rao, Sarika N , Gabriel, Emmanuel M , Rao, Sarika

Mayo Clinic

Journal of Laparoendoscopic & Advanced Surgical Techniques | November 1, 2022 | Volume: 33 | Issue: 2 | Pages: 129-136

10.1089/lap.2022.0302 | PMID 36318793 Get It

Introduction: Nearly half of the adult population in the United States has been diagnosed with hypertension. Adrenal hormonal hypersecretion is a leading cause of secondary hypertension. Adrenal vein sampling (AVS) may assist in differentiating between unilateral and bilateral adrenal hormonal hypersecretion to identify patients who are candidates for adrenalectomy. We reviewed the use of AVS at our institution along with associated outcomes after adrenalectomy. Materials and Methods: A retrospective chart review was conducted of patients with a diagnosis of primary hyperaldosteronism (PA) or adrenocorticotropic hormone-independent Cushing syndrome (AICS) and who underwent adrenalectomy between January 1, 2010, and December 1, 2021. Patient data of baseline characteristics, preoperative workup, including AVS, and postoperative outcomes were collected and analyzed. Results: Seventy-one patients were identified in the study period (48 PA and 23 AICS). Computed tomography scan identified unilateral adrenal nodules in 52 patients (29 left; and 23 right), bilateral nodules in 13 patients, and no nodules in 6 patients. AVS was performed in 45 patients with PA (93%) and 5 patients with AICS (21%). After surgery, the number of PA patients with hypokalemia or requiring potassium supplementation significantly decreased after adrenalectomy (before surgery: 33 [68.7%]; and after surgery: 5 [10.4%], P < .01). The number of medications required for hypertension in AICS patients also significantly decreased. No major adverse events were noted. Conclusions : Our long-term experience demonstrates the ongoing use of AVS during workup of patients with primary hyperaldosteronism and for select patients with adrenocorticotropic hormone-independent Cushing syndrome. However, a low level of discordance between imaging and AVS findings in PA patients suggests that there may be a subset of patients in whom preoperative AVS is not necessary.
Letter to the Editor: The Effectiveness of Empathic Communication Training on Goals of Care and End-of-Life Conversations
Lagunas, Meg , Petit, Samuel D., Deming, James, Horecki, Patty, Brustad, Rebecca, Manz, James, Okuno, Scott H. , Christensen, Susan M., Manz, James W., Petit, Sam D., Deming, James R.

Mayo Clinic

Journal of Palliative Medicine | November 1, 2022 | Volume: 25 | Issue: 11 | Pages: 1616-1617

10.1089/jpm.2022.0291 | PMID 36608318 Get It

Epilepsy center characteristics and geographic region influence presurgical testing in the United States
Ahrens, Stephanie M. , Arredondo, Kristen H. , Bagić, Anto , Bai, Shasha , Chapman, Kevin , Ciliberto, Michael A. , Clarke, Dave , Fountain, Nathan B. , Gavvala, Jay R. , Perry, Μ. Scott , Herman, Susan T. , Ostendorf, Adam P. , Bagić, Anto I , Fountain, Nathan , Gavvala, Jay R , Perry, Michael Scott , Rossi, Kyle C , Wong-Kisiel, Lily C. , Ostendorf, Adam P , Arredondo, Kristen H , Eisner, Mariah , Wong‐Kisiel, Lily C.

Mayo Clinic

Epilepsia | November 1, 2022 | Volume: 64 | Issue: 1 | Pages: 127-138

10.1111/epi.17452 | PMID 36317952 Get It

Abstract Objective Persons with drug‐resistant epilepsy may benefit from epilepsy surgery and should undergo presurgical testing to determine potential candidacy and appropriate intervention. Institutional expertise can influence use and availability of evaluations and epilepsy surgery candidacy. This census survey study aims to examine the influence of geographic region and other center characteristics on presurgical testing for medically intractable epilepsy. Methods We analyzed annual report and supplemental survey data reported in 2020 from 206 adult epilepsy center directors and 136 pediatric epilepsy center directors in the United States. Test utilization data were compiled with annual center volumes, available resources, and US Census regional data. We used Wilcoxon rank‐sum, Kruskal–Wallis, and chi‐squared tests for univariate analysis of procedure utilization. Multivariable modeling was also performed to assign odds ratios (ORs) of significant variables. Results The response rate was 100% with individual element missingness < 11% across 342 observations undergoing univariate analysis. A total of 278 complete observations were included in the multivariable models, and significant regional differences were present. For instance, compared to centers in the South, those in the Midwest used neuropsychological testing (OR = 2.87, 95% confidence interval [CI] = 1.2–6.86; p = .018) and fluorodeoxyglucose–positron emission tomography (OR = 2.74, 95% CI = = 1.14–6.61; p = .025) more commonly. For centers in the Northeast (OR = .46, 95% CI = .23–.93; p = .031) and West (OR = .41, 95% CI = .19–.87; p = .022), odds of performing single‐photon emission computerized tomography were lower by nearly 50% compared to those in the South. Center accreditation level, demographics, volume, and resources were also associated with varying individual testing rates. Significance Presurgical testing for drug‐resistant epilepsy is influenced by US geographic region and other center characteristics. These findings have potential implications for comparing outcomes between US epilepsy centers and may inject disparities in access to surgical treatment.
Care of the Fetus With Congenital Cardiovascular Disease: From Diagnosis to Delivery
Haxel, Caitlin , Johnson, Jonathan N. , Hintz, Susan R. , Renno, Markus S. , Zyblewski, Sinai C. , Glickstein, Julie S. , Ruano, Rodrigo , Donofrio, Mary T.

Mayo Clinic

Pediatrics | November 1, 2022 | Volume: 150 | Issue: Supplement 2 | Pages: No page available

10.1542/peds.2022-056415c | PMID 36317976 Get It

The majority of congenital cardiovascular disease including structural cardiac defects, abnormalities in cardiac function, and rhythm disturbances can be identified prenatally using screening obstetrical ultrasound with referral for fetal echocardiogram when indicated. Diagnosis of congenital heart disease in the fetus should prompt assessment for extracardiac abnormalities and associated genetic abnormalities once parental consent is obtained. Pediatric cardiologists, in conjunction with maternal-fetal medicine, neonatology, and cardiothoracic surgery subspecialists, should counsel families about the details of the congenital heart defect as well as prenatal and postnatal management. Prenatal diagnosis often leads to increased maternal depression and anxiety; however, it decreases morbidity and mortality for many congenital heart defects by allowing clinicians the opportunity to optimize prenatal care and plan delivery based on the specific lesion. Changes in prenatal care can include more frequent assessments through the remainder of the pregnancy, maternal medication administration, or, in selected cases, in utero cardiac catheter intervention or surgical procedures to optimize postnatal outcomes. Delivery planning may include changing the location, timing or mode of delivery to ensure that the neonate is delivered in the most appropriate hospital setting with the required level of hospital staff for immediate postnatal stabilization. Based on the specific congenital heart defect, prenatal echocardiogram assessment in late gestation can often aid in predicting the severity of postnatal instability and guide the medical or interventional level of care needed for immediate postnatal intervention to optimize the transition to postnatal circulation.
Examining the effectiveness of a lower back exoskeleton in reducing discomfort and workload in vascular surgery
Wang, Tianke , Tetteh, Emmanuel , Smith, Tianqi Gao, Mendes, Bernardo C. , Tetteh, Emmanuel , Norasi, Hamid , Hallbeck, M. Susan

Mayo Clinic

Proceedings of the Human Factors and Ergonomics Society Annual Meeting | October 28, 2022 | Volume: 66 | Issue: 1 | Pages: 2153-2157

10.1177/1071181322661169 Get It

Musculoskeletal disorders and intraoperative pain are prevalent among vascular surgeons which can negatively affect their surgical performance and quality of life. The effectiveness of a lower back support exoskeleton to reduce discomfort of the back, subjective fatigue, and the workload associated with performing vascular surgery was evaluated, as well as the participants’ intraoperative upper body postures. Three vascular surgeons were asked to rate their discomfort and fatigue before, during and after performing surgery, and their subjective workload post-operatively. Inertial measurement units (IMUs) were used to measure their intraoperative body postures. No significant differences were found between exoskeleton and baseline discomfort, fatigue, workload, or intraoperative postures. This indicates that although the exoskeleton did not restrict the vascular surgeons’ postures, this exoskeleton was ineffective at reducing their discomfort or workload. Future studies with exoskeletons specifically designed for healthcare applications may show more efficacy in reducing the ergonomic risks to surgeons.
Comparison of physical workload in upper extremities between left- and right-hand ultrasound scanning
Tetteh, Emmanuel , Wang, Tianke, Bremer, Merri L., Schmida, Elizabeth , Kim, Joseph , Koenig, Jordyn , Tetteh, Emmanuel , Kim, Joseph Y , Wang, Tianke , Norasi, Hamid , Fortune, Emma , Kane, Garvan C. , Hallbeck, M. Susan

Mayo Clinic

Proceedings of the Human Factors and Ergonomics Society Annual Meeting | October 28, 2022 | Volume: 66 | Issue: 1 | Pages: 651-655

10.1177/1071181322661144 Get It

Ames, IA Cardiac sonographers suffer from high prevalence of work-related upper extremity musculoskeletal pain due to awkward postures and fatigue accumulation. Sonographers can choose either left- or right-hand scanning, or alternate between both, however, the impact of each scanning technique on the upper extremity muscles remains unknown. Four ambidextrous cardiac sonographers performed between four to six cardiac scans using left- and right-hand while postural and muscle activity were collected from specific muscles on the upper extremities. A comparison of the posture showed that apart from forearm pitch and 90 th percentile upper arm deviation, upper extremity postures between the two scanning techniques did not differ significantly. Furthermore, while right-hand scanning (RHS) appeared to induce slightly higher muscle activity in the deltoids compared to left-hand scanning (LHS), the difference between the two techniques was not significant. We recommend alternating between these two techniques to distribute muscle stress evenly to prevent muscle overuse.
Intraoperative teamwork and workload among surgeons and surgical trainees during DIEP flap surgery
Tetteh, Emmanuel , Wang, Tianke , Harless, Christin A., Nguyen, Minh-Doan T. , Tetteh, Emmanuel , Norasi, Hamid , Hallbeck, M. Susan

Mayo Clinic

Proceedings of the Human Factors and Ergonomics Society Annual Meeting | October 28, 2022 | Volume: 66 | Issue: 1 | Pages: 575-579

10.1177/1071181322661115 Get It

Two attending surgeons (surgeon at abdomen and surgeon at chest) and nine surgical trainees completed electronic surveys after deep inferior epigastric perforator (DIEP) flap surgical procedures. The survey included workload and teamwork subscales. The results indicated that DIEP flap surgery is a highly demanding surgical procedure both physically and cognitively. For the surgeon at abdomen, most of workload subscales were significantly higher than the paired trainees (p<0.05), while their teamwork subscales were not significantly different. The surgical trainees should know that the attending surgeon’s self-perceived workload could be higher than theirs even when their self-perceived teamwork is similar. For the surgeon at chest, most of teamwork subscales were significantly higher than the paired trainees (p<0.05), while their workload subscales were not significantly different. The attending surgeons should know that even when their self-evaluation of workload is similar to their trainees, the trainee’s evaluation of teamwork could be less than theirs.
Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations
Brastianos, Priscilla K. , Twohy, Erin , Gerstner, Elizabeth R. , Kaufmann, Timothy J. , Iafrate, A. John , Lennerz, Jochen K. , Jeyapalan, Suriya, Monga, Varun , Fadul, Camilo E. , Schiff, David , Taylor, Jennie , Chowdhary, Sajeel, Ansstas, George , Fuente, Macarena I. de la , Anderson, Mark D. , Shonka, Nicole , Damek, Denise, Ronan, Lara Kunschner , Chaudhary, Rekha , Jaeckle, Kurt A. , Senecal, Francis M. , Morrison, Tara, Thomas, Alissa A. , Welch, Mary , Cachia, David , Cohen, Adam L. , Vora, Shivangi, Knopp, Michael V. , Dunn, Ian F. , Kumthekar, Priya , Geyer, Susan M. , Carrero, Xiomara W., Brown, Paul D. , Barker, Frederick G., Twohy, Erin L , Lennerz, Jochen , Monga, Varun , Fadul, Camilo E , Taylor, Jennie W , De La Fuente, Macarena , Anderson, Mark D , Shonka, Nicole , Kunschner-Ronan, Lara J , Jaeckle, Kurt A , Kaley, Thomas , Knopp, Michael , Kumthekar, Priya , Sarkaria, Jann, Martinez-Lage, Maria , Brown, Paul D , Kaufmann, Timothy J , Piccioni, David Eric , Bettegowda, Chetan , Carrillo, Jose , IWAMOTO, FABIO MASSAITI , Sarkaria, Jann N. , Martinez‐Lage, Maria , Cahill, Daniel P. , Giannini, Caterina , Santagata, Sandro , Galanis, Evanthia

Mayo Clinic

Journal of Clinical Oncology | October 26, 2022 | Volume: 41 | Issue: 3 | Pages: 618-628

10.1200/jco.21.02371 | PMID 36288512 Get It

PURPOSE Patients with progressive or recurrent meningiomas have limited systemic therapy options. Focal adhesion kinase (FAK) inhibition has a synthetic lethal relationship with NF2 loss. Given the predominance of NF2 mutations in meningiomas, we evaluated the efficacy of GSK2256098, a FAK inhibitor, as part of the first genomically driven phase II study in recurrent or progressive grade 1-3 meningiomas. PATIENTS AND METHODS Eligible patients whose tumors screened positively for NF2 mutations were treated with GSK2256098, 750 mg orally twice daily, until progressive disease. Efficacy was evaluated using two coprimary end points: progression-free survival at 6 months (PFS6) and response rate by Macdonald criteria, where PFS6 was evaluated separately within grade-based subgroups: grade 1 versus 2/3 meningiomas. Per study design, the FAK inhibitor would be considered promising in this patient population if either end point met the corresponding decision criteria for efficacy. RESULTS Of 322 patients screened for all mutation cohorts of the study, 36 eligible and evaluable patients with NF2 mutations were enrolled and treated: 12 grade 1 and 24 grade 2/3 patients. Across all grades, one patient had a partial response and 24 had stable disease as their best response to treatment. In grade 1 patients, the observed PFS6 rate was 83% (10/12 patients; 95% CI, 52 to 98). In grade 2/3 patients, the observed PFS6 rate was 33% (8/24 patients; 95% CI, 16 to 55). The study met the PFS6 efficacy end point both for the grade 1 and the grade 2/3 cohorts. Treatment was well tolerated; seven patients had a maximum grade 3 adverse event that was at least possibly related to treatment with no grade 4 or 5 events. CONCLUSION GSK2256098 was well tolerated and resulted in an improved PFS6 rate in patients with recurrent or progressive NF2-mutated meningiomas, compared with historical controls. The criteria for promising activity were met, and FAK inhibition warrants further evaluation for this patient population.
The effect of burosumab on intact and C‐terminal FGF23 measurements
Ashrafzadeh‐Kian, Susan , Ito, Nobuaki , Sethna, Christine B. , Garg, Uttam, Katô, Hajime , Bornhorst, Joshua A. , Ashrafzadeh-Kian, Susan Louise , Srivastava, Tarak , Bornhorst, Joshua , Algeciras‐Schimnich, Alicia

Mayo Clinic

Clinical Endocrinology | October 20, 2022 | Volume: 99 | Issue: 2 | Pages: 152-157

10.1111/cen.14832 | PMID 36263608 Get It

AbstractObjectiveTo investigate the effect of CRYSVITA® (burosumab‐twza) on FGF23 measurements in an intact and a C‐terminal immunoassay.MethodsAn intact serum FGF23 (MedFrontier) and a C‐terminal plasma FGF23 assay (Immutopics) were used. Serum/plasma pools were spiked to span the burosumab therapeutic range (1.4–11.3 μg/ml) and FGF23 recovery was assessed. Patient serum and plasma samples obtained pre and post‐burosumab treatment were evaluated on both assays and compared with corresponding phosphorus measurementsResultsSpiking burosumab (1.4–11.3 μg/ml) into sample pools resulted in a dose‐dependent negative analytical interference on intact FGF23 measurements and no significant interference for C‐terminal FGF23 measurements. However, more than a 500‐fold median increase (post‐ vs. pre‐burosumab administration) in in vivo FGF23 concentrations were observed by both assays.ConclusionsTherapeutic concentrations of burosumab result in a negative analytical interference of the intact, but not the C‐terminal FGF23 immunoassay. Despite this in vitro analytical interference in the intact assay, relatively large elevations of both intact FGF23 and C‐terminal FGF23 measurements were observed in vivo following burosumab administration. Following burosumab administration, FGF23 measurements must be interpreted within the clinical context of the patient and other relevant biomarker results.SummaryThis article describes a negative analytical interference by burosumab in an intact FGF23 immunoassay. The recovery of C‐terminal FGF23 is not significantly affected by the presence of burosumab. In vivo, both assays demonstrate extreme FGF23 elevations in the presence of the drug. Furthermore, the measurement of FGF23 blocked by burosumab is not clinically useful regarding hypophosphataemia.
Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors
Thibord, Florian , Klarin, Derek , Brody, Jennifer A. , Chen, Ming‐Huei , Levin, Michael G. , Chasman, Daniel I. , Goode, Ellen L. , Teder‐Laving, Maris , Martínez-Pérez, Ángel , Daian-Bacq, Delphine, Ito, Kaoru , Natarajan, Pradeep , Lutsey, Pamela L. , Nadkarni, Girish N. , Vries, Paul S. de , Wolford, Brooke N. , Pattee, Jack , Brækkan, Sigrid K. , Li‐Gao, Ruifang , Saut, Noémie , Sept, Corriene, Judy, Renae , O’Donnell, Christopher J. , Giulianini, Franco, Boland, Anne , Empana, Jean‐Philippe , Gilliland, Thomas , Do, Ron , Wang, Xin , Zhou, Wei , Soria, José Manuel , Souto, Juan Carlos , Haessler, Jeffery, Hindberg, Kristian , Bartz, Traci M. , Heckbert, Susan R. , Armasu, Sebastian M. , Brumpton, Ben , Smadja, David M. , Jouven, Xavier , Loos, Ruth J. F. , Sabater‐Lleal, Maria , Pankow, James S. , Reiner, Alex P. , Vlieg, Astrid van Hylckama , Deleuze, Jean-François, Skogholt, Anne Heidi , Emmerich, Joseph , Tang, Weihong , Jackson, Rebecca D. , Hansen, John‐Bjarne , Morange, Pierre‐Emmanuel , Kabrhel, Christopher , Johnson, Andrew D. , Smith, Nicholas L. , Martinez-Perez, Angel , Aïssi, Dylan , Ito, Kaoru , Natarajan, Pradeep , Lutsey, Pamela L , Nadkarni, Girish N , de Vries, Paul S , Wolford, Brooke N , Kooperberg, Charles , Braekkan, Sigrid K , Li-Gao, Ruifang , Saut, Noemie , Germain, Marine , Wiggins, Kerri L , Ko, Darae , O'Donnell, Christopher J , Taylor, Kent D , de Andrade, Mariza , Nøst, Therese H , Boland, Anne , Empana, Jean Philippe , Gilliland, Thomas , Do, Ron , Wang, Xin , Manuel Soria, Jose , Carlos Souto, Juan , Pankratz, Nathan , Rosendaal, Frits R , Turman, Constance , Olaso, Robert , Bartz, Traci M , Lynch, Julie A , Heckbert, Susan R , Brumpton, Ben , Smadja, David M , Komuro, Issei , Clapham, Katharine R , Loos, Ruth J F , Willer, Cristen J , Sabater-Lleal, Maria , Pankow, James S , Reiner, Alexander P , Ridker, Paul M. , Rader, Daniel J , Min Lee, Kyung , Psaty, Bruce M , Rich, Stephen S , Vy, Ha My T , Tang, Weihong , Damrauer, Scott M , Johnson, Andrew D , Smith, Nicholas L , Chasman, Daniel I , Brody, Jennifer A , Hveem, Kristian , Cuéllar-Partida, Gabriel , Kooperberg, Charles , Germain, Marine , Wiggins, Kerri L. , Taylor, Kent D. , Andrade, Mariza de , Koyama, Satoshi , Huffman, Jennifer E. , Pankratz, Nathan , Turman, Constance , Kember, Rachel L. , Lynch, Julie A. , Morelli, Vânia Maris , Deleuze, Jean‐François , Kraft, Peter , Lee, Kyung Min , Psaty, Bruce M. , Suchon, Pierre , Rich, Stephen S. , Trégouët, David‐Alexandre

Mayo Clinic

Circulation | October 17, 2022 | Volume: 146 | Issue: 16 | Pages: 1225-1242

10.1161/circulationaha.122.059675 | PMID 36154123 Get It

Background: Venous thromboembolism (VTE) is a life-threatening vascular event with environmental and genetic determinants. Recent VTE genome-wide association studies (GWAS) meta-analyses involved nearly 30 000 VTE cases and identified up to 40 genetic loci associated with VTE risk, including loci not previously suspected to play a role in hemostasis. The aim of our research was to expand discovery of new genetic loci associated with VTE by using cross-ancestry genomic resources. Methods: We present new cross-ancestry meta-analyzed GWAS results involving up to 81 669 VTE cases from 30 studies, with replication of novel loci in independent populations and loci characterization through in silico genomic interrogations. Results: In our genetic discovery effort that included 55 330 participants with VTE (47 822 European, 6320 African, and 1188 Hispanic ancestry), we identified 48 novel associations, of which 34 were replicated after correction for multiple testing. In our combined discovery-replication analysis (81 669 VTE participants) and ancestry-stratified meta-analyses (European, African, and Hispanic), we identified another 44 novel associations, which are new candidate VTE-associated loci requiring replication. In total, across all GWAS meta-analyses, we identified 135 independent genomic loci significantly associated with VTE risk. A genetic risk score of the significantly associated loci in Europeans identified a 6-fold increase in risk for those in the top 1% of scores compared with those with average scores. We also identified 31 novel transcript associations in transcriptome-wide association studies and 8 novel candidate genes with protein quantitative-trait locus Mendelian randomization analyses. In silico interrogations of hemostasis and hematology traits and a large phenome-wide association analysis of the 135 GWAS loci provided insights to biological pathways contributing to VTE, with some loci contributing to VTE through well-characterized coagulation pathways and others providing new data on the role of hematology traits, particularly platelet function. Many of the replicated loci are outside of known or currently hypothesized pathways to thrombosis. Conclusions: Our cross-ancestry GWAS meta-analyses identified new loci associated with VTE. These findings highlight new pathways to thrombosis and provide novel molecules that may be useful in the development of improved antithrombosis treatments.